Similarly, TLR9 exacerbates AKI by sensing mitochondrial DNA released from injured tubular cells, triggering innate immune activation and amplifying systemic inflammation and mortality in ischemia-reperfusion models supplemented with mitochondrial injection (82). This evidence concerns the gene TLR9 and acute kidney injury.